These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 32507279)
1. NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis. Ji X; Li L; Lu P; Li X; Tian D; Liu M Biochem Biophys Res Commun; 2020 Jul; 528(3):485-492. PubMed ID: 32507279 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3. Li H; Zhang L; Cai N; Zhang B; Sun S Ann Hepatol; 2021; 23():100305. PubMed ID: 33434689 [TBL] [Abstract][Full Text] [Related]
3. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903 [TBL] [Abstract][Full Text] [Related]
4. Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis. Poulsen KL; Fan X; Kibler CD; Huang E; Wu X; McMullen MR; Leng L; Bucala R; Ventura-Cots M; Argemi J; Bataller R; Nagy LE JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33945507 [TBL] [Abstract][Full Text] [Related]
5. Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis. Furuya S; Cichocki JA; Konganti K; Dreval K; Uehara T; Katou Y; Fukushima H; Kono H; Pogribny IP; Argemi J; Bataller R; Rusyn I Toxicol Sci; 2019 Aug; 170(2):427-437. PubMed ID: 30517762 [TBL] [Abstract][Full Text] [Related]
6. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218 [TBL] [Abstract][Full Text] [Related]
7. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Affò S; Morales-Ibanez O; Rodrigo-Torres D; Altamirano J; Blaya D; Dapito DH; Millán C; Coll M; Caviglia JM; Arroyo V; Caballería J; Schwabe RF; Ginès P; Bataller R; Sancho-Bru P Gut; 2014 Nov; 63(11):1782-92. PubMed ID: 24415562 [TBL] [Abstract][Full Text] [Related]
8. Circular RNA expression profile of liver tissues in an EtOH-induced mouse model of alcoholic hepatitis. Meng H; Wang L; You H; Huang C; Li J Eur J Pharmacol; 2019 Nov; 862():172642. PubMed ID: 31493407 [TBL] [Abstract][Full Text] [Related]
9. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis. Furuya S; Argemi J; Uehara T; Katou Y; Fouts DE; Schnabl B; Dubuquoy L; Belorkar A; Vadigepalli R; Kono H; Bataller R; Rusyn I Alcohol Clin Exp Res; 2020 Jan; 44(1):87-101. PubMed ID: 31710124 [TBL] [Abstract][Full Text] [Related]
10. Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells. Wu N; McDaniel K; Zhou T; Ramos-Lorenzo S; Wu C; Huang L; Chen D; Annable T; Francis H; Glaser S; Alpini G; Meng F Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G385-G398. PubMed ID: 29848019 [TBL] [Abstract][Full Text] [Related]
11. CCL20 induced by visfatin in macrophages via the NF-κB and MKK3/6-p38 signaling pathways contributes to hepatic stellate cell activation. Heo YJ; Choi SE; Lee N; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ Mol Biol Rep; 2020 Jun; 47(6):4285-4293. PubMed ID: 32418112 [TBL] [Abstract][Full Text] [Related]
12. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression. Ignacio RM; Kabir SM; Lee ES; Adunyah SE; Son DS PLoS One; 2016; 11(10):e0164189. PubMed ID: 27723802 [TBL] [Abstract][Full Text] [Related]
13. MiR-451a ameliorates alcoholic hepatitis via repressing HDAC8-mediated proinflammatory response. Du B; Tan XH; Cheng L; Wang F; Zhang HF Kaohsiung J Med Sci; 2020 Nov; 36(11):904-910. PubMed ID: 32643864 [TBL] [Abstract][Full Text] [Related]
14. NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease. Mainz RE; Albers S; Haque M; Sonntag R; Treichel NS; Clavel T; Latz E; Schneider KM; Trautwein C; Otto T Cells; 2022 Jan; 11(2):. PubMed ID: 35053298 [TBL] [Abstract][Full Text] [Related]
15. A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD Kang H; Kim MB; Park YK; Lee JY J Nutr Biochem; 2022 Jan; 99():108852. PubMed ID: 34525389 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590 [TBL] [Abstract][Full Text] [Related]
17. Biphasic Ccl20 regulation by Toll-like receptor 9 through the activation of ERK-AP-1 and non-canonical NF-κB signaling pathways. Dutta P; Ta A; Thakur BK; Dasgupta N; Das S Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3365-3377. PubMed ID: 27590109 [TBL] [Abstract][Full Text] [Related]
18. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway. Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340 [TBL] [Abstract][Full Text] [Related]
19. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Zhao J; Zhang Z; Luan Y; Zou Z; Sun Y; Li Y; Jin L; Zhou C; Fu J; Gao B; Fu Y; Wang FS Hepatology; 2014 Apr; 59(4):1331-42. PubMed ID: 24677193 [TBL] [Abstract][Full Text] [Related]